| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |